Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration
- PMID: 10201024
- DOI: 10.1046/j.1523-1755.1999.00397.x
Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration
Abstract
Background: Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration (CVVH). Despite adequate exogenous anticoagulation, the occlusion of CVVH circuits can occur within minutes to a few hours of use and is associated with evidence of thrombin generation. Having found no evidence of activation of the contact factor (intrinsic coagulation) pathway during CVVH, we sought to examine the effect of the first episode of CVVH on the tissue factor (extrinsic) pathway of coagulation and thrombin generation.
Methods: Twelve critically ill patients were studied prior to the commencement of hemofiltration and at regular intervals thereafter until the filter clotted.
Results: Prior to hemofiltration, most patients had increased levels of plasma tissue factor, thrombin-antithrombin (TAT) complexes, and tissue factor pathway inhibitor (TFPI); during hemofiltration, further generation of TAT complexes occurred. Initially, levels of activated factor VII (FVIIa) fell and TFPI increased, but during the course of hemofiltration, the levels of TFPI fell and FVIIa increased. Levels of tissue factor increased during CVVH in some patients, but this was not related to the generation of FVIIa.
Conclusions: These data indicate that activation of FVII occurred during CVVH, which was related to levels of TFPI, but not tissue factor, and was coincidental to thrombin generation.
Similar articles
-
The effects of continuous venovenous hemofiltration on coagulation activation.Crit Care. 2006;10(5):R150. doi: 10.1186/cc5080. Crit Care. 2006. PMID: 17069648 Free PMC article.
-
Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.J Cardiothorac Vasc Anesth. 2001 Feb;15(1):60-4. doi: 10.1053/jcan.2001.20278. J Cardiothorac Vasc Anesth. 2001. PMID: 11254842
-
Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates.Crit Care. 2009;13(6):R193. doi: 10.1186/cc8191. Epub 2009 Dec 3. Crit Care. 2009. PMID: 19958532 Free PMC article. Clinical Trial.
-
Tissue factor pathway.Baillieres Best Pract Res Clin Haematol. 1999 Sep;12(3):361-72. doi: 10.1053/beha.1999.0030. Baillieres Best Pract Res Clin Haematol. 1999. PMID: 10856975 Review.
-
TFPI-dependent activities of protein S.Thromb Res. 2012 May;129 Suppl 2:S23-6. doi: 10.1016/j.thromres.2012.02.024. Epub 2012 Mar 15. Thromb Res. 2012. PMID: 22425215 Review.
Cited by
-
Direct thrombin inhibitors: pharmacology and application in intensive care medicine.Intensive Care Med. 2010 Jul;36(7):1127-37. doi: 10.1007/s00134-010-1888-3. Epub 2010 Apr 28. Intensive Care Med. 2010. PMID: 20425104 Review.
-
Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?Intensive Care Med. 2006 Feb;32(2):188-202. doi: 10.1007/s00134-005-0044-y. Epub 2006 Feb 2. Intensive Care Med. 2006. PMID: 16453140
-
Clinical review: Patency of the circuit in continuous renal replacement therapy.Crit Care. 2007;11(4):218. doi: 10.1186/cc5937. Crit Care. 2007. PMID: 17634148 Free PMC article. Review.
-
Incorporation of oXiris Bioabsorbent Filter into CRRT in the treatment of severe abdominal infections and analysis of associated risk factors for early off-machine.Front Public Health. 2025 Jul 30;13:1560587. doi: 10.3389/fpubh.2025.1560587. eCollection 2025. Front Public Health. 2025. PMID: 40809760 Free PMC article.
-
Extracorporeal organ support and the kidney.Front Nephrol. 2022 Aug 5;2:924363. doi: 10.3389/fneph.2022.924363. eCollection 2022. Front Nephrol. 2022. PMID: 37674997 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous